These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An overview of the status of the nitrosoureas in other tumors. Carter SK Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034 [No Abstract] [Full Text] [Related]
4. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites? Eckhardt S; Kerpel-Fronius S; Horváth IP; Institoris L Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):783-8. PubMed ID: 3985644 [No Abstract] [Full Text] [Related]
5. [Therapy using cytostatics. Desired and undesired effects]. Hartwich G Fortschr Med; 1973 Nov; 91(31):1218-22. PubMed ID: 4751347 [No Abstract] [Full Text] [Related]
6. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037). Einhorn LH; Livingston RB; Gottlieb JA Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951 [No Abstract] [Full Text] [Related]
7. Biochemical aspects of drug combinations. Brockman RW Cancer Chemother Rep 2; 1974 Mar; 4(1):115-29. PubMed ID: 4135108 [No Abstract] [Full Text] [Related]
8. Advanced cancer: New concepts of medical therapy. Geriatrics; 1973 Nov; 28(11):51-72. PubMed ID: 4796352 [No Abstract] [Full Text] [Related]
9. Solid tumor chemotherapy: new drugs and horizons. Yardumian H J Am Osteopath Assoc; 1974 Dec; 74(4):299-306. PubMed ID: 4140203 [No Abstract] [Full Text] [Related]
10. The use of drugs in combination for the treatment of cancer: rationale and results. DeVita VT; Schein PS N Engl J Med; 1973 May; 288(19):998-1006. PubMed ID: 4348752 [No Abstract] [Full Text] [Related]
11. [Corticosteroids in oncology]. Cleton FJ Ned Tijdschr Geneeskd; 1977 Oct; 121(43):1715-20. PubMed ID: 270013 [No Abstract] [Full Text] [Related]
12. Drug management of malignant disease. Fennelly JJ Ir Med J; 1983 Jul; 76(7):326-31. PubMed ID: 6350216 [No Abstract] [Full Text] [Related]
13. [General principles and new trends of cytostatic tumor therapy]. Holfeld H; Bamberg M Strahlentherapie; 1980 May; 156(5):297-307. PubMed ID: 7190333 [No Abstract] [Full Text] [Related]
14. Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute. Carter SK; Slavik M Natl Cancer Inst Monogr; 1977 Mar; (45):101-21. PubMed ID: 73134 [No Abstract] [Full Text] [Related]
15. [Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy)]. Clavel B Sem Hop; 1974 Jan; 50(4):287-95. PubMed ID: 4368180 [No Abstract] [Full Text] [Related]
17. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia. Frei E; Schabel FM; Goldin A Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419 [No Abstract] [Full Text] [Related]
18. [Testicular infiltration in acute lymphoblastic leukemia in childhood]. Uderzo C; Cantù Rajnoldi A; Ferrari M; Mauri R; Vitali M Minerva Pediatr; 1980 Feb; 32(4):231-5. PubMed ID: 6929949 [No Abstract] [Full Text] [Related]
19. [Guidelines in the therapy of various neoplastic diseases with cytostatic drugs]. Bollag W Praxis; 1969 Jun; 58(22):703-7. PubMed ID: 5258076 [No Abstract] [Full Text] [Related]
20. Adriamycin. A new anticancer drug with significant clinical activity. Blum RH; Carter SK Ann Intern Med; 1974 Feb; 80(2):249-59. PubMed ID: 4590654 [No Abstract] [Full Text] [Related] [Next] [New Search]